Elsulfavirine

DB14929InvestigationalSmall molecule

Elsulfavirine is under investigation in clinical trial NCT03706898 (Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact...

Mechanism: Pharmacologically active on Reverse transcriptase/RNaseH, Insulin-induced gene 1 protein, and Adenylosuccinate lyase
Curator reviewed
Formula / weight: C₂₄H₁₇BrCl₂FN₃O₅S · 629.28 g/mol (avg)
Code names: VM-1500

Resolves to

Compound

UNIIZC4CGO0RUGCAS868046-19-9

Clinical / RWD

ATCJ05AG07

Structure

InChIKeyULTDEARCBRNRGR-UHFFFAOYSA-NSMILESCCC(=O)NS(=O)(=O)C1=CC(Cl)=C(NC(=O)CC2=CC=C(Br)C(OC3=CC(=CC(Cl)=C3)C#N)=C2F)C=C1

Targets

Q72547polO15503INSIG1P30566ADSLQ9Y5U4INSIG2

What you can answer from here — as of July 07, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 18 drug categories

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Elsulfavirine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In